USPTO serial 98182283
REVMED
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 9, 2025
- Examiner
- CLONCH, ABIGAIL
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with REVMED?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Melissa A. Nowak
Melissa A. Nowak CHRISTENSEN O'CONNOR JOHNSON KINDNESS1201 THIRD AVENUE, SUITE 3600SEATTLE, WA 98101United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in the treatment of cancer and oncological diseases and disorders; pharmaceutical preparations for use in immuno-oncology; pharmaceutical preparations for use in the treatment of immunological diseases and disorders | ACTIVE | Jan 12, 2024 |
| 042 | Pharmaceutical research and development; drug discovery services; Providing information about medical and scientific research via a website | ACTIVE | Dec 13, 2023 |
| 044 | Providing medical information via a website; providing health information via a website; providing information to patients and healthcare professionals via a website relating to disease diagnosis, management, and treatment options in the field of oncological and immune system related diseases and disorders | ACTIVE | Dec 13, 2023 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Revolution Medicines, Inc.
- Other trademarks owned by Revolution Medicines, Inc.
- Other trademarks owned by Revolution Medicines, Inc.
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named REVMED
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 9, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Sep 9, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 18, 2025 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Aug 18, 2025 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Aug 18, 2025 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Aug 15, 2025 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Dec 10, 2024 | IUAF | USE AMENDMENT FILED | — |
| Dec 10, 2024 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Nov 26, 2024 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Oct 15, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 15, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 25, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 11, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 10, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 10, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 10, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 10, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 6, 2024 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| May 28, 2024 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| May 14, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 13, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 13, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 13, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 13, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 9, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 4, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 19, 2023 | NWAP | NEW APPLICATION ENTERED | — |